Best in 7 days In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintide–semaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results US$ 24.76 Sold : Login>>
Best in 7 days Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 29.87 Sold : Login>>
Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports US$ 28.24 Min. order: 1 piece ★★★★★ 4.9 (242 reviews) Sold : Login>>
The Influence of Glucagon-like Peptide-1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition US$ 20.04 Min. order: 1 piece ★★★★★ 4.9 (211 reviews) Sold : Login>>
CJC-1295/Ipamorelin Dosage Protocol: The Complete Clinical Guide to Dosing, Cycling, and Injection US$ 23.50 Min. order: 1 piece ★★★★★ 4.1 (258 reviews) Sold : Login>>
CJC-1295 NO DAC 2mg + Ipamorelin 2mg + BPC-157 5mg US$ 26.02 Min. order: 1 piece ★★★★★ 4.0 (143 reviews) Sold : Login>>
What is the pipeline for future medications for obesity? US$ 22.52 Min. order: 1 piece ★★★★★ 4.6 (189 reviews) Sold : Login>>